An Early Phase 1 interventional study of Passive Heating and L-NAME in Aging, sponsored by William Hughes. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-09.
Sponsored by William Hughes · Early Phase 1, Interventional, and Basic science
Vascular dysfunction is a common factor in many chronic debilitating diseases, contributing to morbidity and mortality. With the onset of chronic disease or exposure to stress, the vasculature displays an inability to adequately respond to increased blood flow demands, manifesting in a reduced ability or altered mechanism of vasodilation. Aging is an independent risk factor in the development of cardiovascular disease, and reduces vasodilator capacity, or alters the mechanism by which vasodilation occurs in multiple vascular beds. Chronic exercise/physical activity is one of the most potent ways to enhance vascular function, resulting in favorable outcomes such as reductions in blood pressure, and improved ability to perform activities of daily living. Barriers to exercise or failure of long-term adherence preclude many populations from the cardiovascular benefits of exercise, thus further enhancing cardiovascular risk. Avenues to mimic blood flow patterns observed with exercise may exert beneficial effects without the need for the ability to exercise. Recent evidence has demonstrated that passive heat therapy, or chronic heat exposure (\~ +1°C in core temperature) results in reductions in major adverse cardiovascular events, blood pressure and improved large artery endothelial function, primarily through preservation of large artery function in response to vascular stress. It is unclear whether microvascular function is augmented in response to acute heat exposure, or whether this can protect against vascular insults particularly in older adults. Some preliminary evidence in humans suggest that autophagy, a cell recycling process is involved in the beneficial cardiovascular effects, as short-term heat exposure upregulates markers of autophagy. Previous evidence from our lab indicates that autophagy governs the mechanism by which microvascular vasodilation occurs. The role of autophagy in mediating the beneficial effects of passive heating is unknown.
This is the only study on the registry with William Hughes as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The lower limbs will be immersed in warm circulating water for 60 minutes.
Procedure: Passive Heating · Drug: L-NAME
The lower limbs will be immersed in warm (42C) circulating water for 60 minutes.
L-NAME will be used during measurement of cutaneous microvascular function to test the dependency upon NO to elicit vasodilation.
Change in cutaneous microvascular function
Change in cutaneous microvascular function assessed via microdialysis infusion of acetylcholine (dose response) in the presence and absence of L-NAME to test the dependency upon NO to elicit vasodilation.
Time frame: Baseline, 60 minutes post I/R, and 60 minutes post hot water immersion + I/R injury
Spontaneous baroreflex sensitivity
Change in spontaneous BRS
Time frame: Baseline, 60 minutes post I/R, 60 minutes post hot water immersion + I/R injury
24-hour (Ambulatory) Blood Pressure
Ambulatory blood pressure (systolic, diastolic) for both peripheral and aortic blood pressure
Time frame: Baseline
Change in plasma concentration of heat shock proteins
Change in the plasma concentrations of various heat shock proteins (HSP 70, 90)
Time frame: Baseline and 60 minutes post hot water immersion
Plan to share: Undecided
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.